180 related articles for article (PubMed ID: 11409295)
1. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
[TBL] [Abstract][Full Text] [Related]
2. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
[TBL] [Abstract][Full Text] [Related]
4. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
Antikainen M; Murtomäki S; Syvänne M; Pahlman R; Tahvanainen E; Jauhiainen M; Frick MH; Ehnholm C
J Clin Invest; 1996 Aug; 98(4):883-5. PubMed ID: 8770857
[TBL] [Abstract][Full Text] [Related]
5. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
6. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
[TBL] [Abstract][Full Text] [Related]
9. The relationship of oral disturbances of diabetes mellitus patients with paraoxonase gene polymorphisms.
Unür M; Demirez E; Ağaçhan B; Görmüş U; Ergen A; Dalan B; Isbir T
Cell Biochem Funct; 2008 Dec; 26(8):870-3. PubMed ID: 19003935
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
11. The influence of PON1 192 polymorphism on endothelial function in diabetic subjects with or without hypertension.
Irace C; Cortese C; Fiaschi E; Scavelli F; Liberatoscioli L; Federici G; Gnasso A
Hypertens Res; 2008 Mar; 31(3):507-13. PubMed ID: 18497471
[TBL] [Abstract][Full Text] [Related]
12. The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs.
Gnasso A; Motti C; Irace C; Di Gennaro I; Pujia A; Leto E; Ciamei M; Crivaro A; Bernardini S; Federici G; Cortese C
Atherosclerosis; 2002 Oct; 164(2):289-95. PubMed ID: 12204800
[TBL] [Abstract][Full Text] [Related]
13. The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.
Gluba A; Pietrucha T; Banach M; Piotrowski G; Rysz J
Angiology; 2010 Feb; 61(2):157-65. PubMed ID: 19939821
[TBL] [Abstract][Full Text] [Related]
14. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
[TBL] [Abstract][Full Text] [Related]
15. Determination of paraoxonase (PON1) status requires more than genotyping.
Richter RJ; Furlong CE
Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
[TBL] [Abstract][Full Text] [Related]
16. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
17. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
[TBL] [Abstract][Full Text] [Related]
18. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
Sentí M; Aubó C; Elosua R; Sala J; Tomás M; Marrugat J
Genet Epidemiol; 2000 Mar; 18(3):276-86. PubMed ID: 10723110
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
20. Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease.
Martinelli N; Girelli D; Olivieri O; Cavallari U; Biscuola M; Trabetti E; Friso S; Pizzolo F; Tenuti I; Bozzini C; Villa G; Ceradini B; Sandri M; Cheng S; Grow MA; Pignatti PF; Corrocher R
Clin Exp Med; 2005 May; 5(1):20-30. PubMed ID: 15928879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
